NCT07522450 Benefit of Sleep Quality Monitoring by EEG in ICU
| NCT ID | NCT07522450 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Rouen |
| Condition | Respiratory Failure |
| Study Type | OBSERVATIONAL |
| Enrollment | 47 participants |
| Start Date | 2026-03-04 |
| Primary Completion | 2027-03-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 47 participants in total. It began in 2026-03-04 with a primary completion date of 2027-03-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to learn about the benefit of monitoring sleep quality using EEG in patients hospitalized in critical care unit for acute respiratory failure. The main question it aims to answer is: • Does EEG monitoring improve sleep quality assessment in critically ill patients with acute respiratory failure compared to nurse sleep quality assessment? Participants hospitalized in critical care unit for acute respiratory failure will have their sleep quality assessed by both EEG monitoring and nurse evaluation during their stay in critical care unit.
Eligibility Criteria
Inclusion Criteria: * Adults * Acute respiratory failure with non-invasive ventilation or high-flow oxygenotherapy hospitalized in critical care unit * Conscious * Insurance coverage * Consent to participate Exclusion Criteria: * pregnancy * cutaneous lesion on the scalp * guardianship
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07522450 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Respiratory Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07522450 currently recruiting?
Yes, NCT07522450 is actively recruiting participants. Contact the research team at marieanne.melone@chu-rouen.fr for enrollment information.
Where is the NCT07522450 trial being conducted?
This trial is being conducted at Rouen, France.
Who is sponsoring the NCT07522450 clinical trial?
NCT07522450 is sponsored by University Hospital, Rouen. The trial plans to enroll 47 participants.